2.Minimally invasive treatment of the patients with hemorrhagic moyamoya disease
Chinese Journal of Primary Medicine and Pharmacy 2015;(14):2084-2086
Objective To study the clinical effect of minimally invasive treatment of 24 patients with hemor-rhagic moyamoya disease.Methods The clinical features of onset,bleeding location of the lesions and the type,ther-apeutic results of minimally invasive treatment were studied retrospectively.Results 24 patients with hemorrhagic moyamoya disease spontaneous intracerebral hematoma who need to acutely remove the hematoma were examined by CT angiography ( CTA) .Emergency minimal invasive puncture was performed according to the result of CTA,and the role of CTA in operation was analyzed.In all 24 patients,most of them were cerebral hemorrhage breaking into ventri-cles,5 cases with intracranial aneurysm.In all the hemisphere of hemorrhage,dilatation and abnormal branching of the AchA and P-CoM were observed in 9 patients,superficial temporal artery.Conclusion Minimally invasive treat-ment of hemorrhagic moyamoya disease scheme is simple,practical and effective,the maneuverability is strong.
3.The effect of intranasal instillation of insulin on cognitive function in patients with Alzheimer disease
Chinese Journal of Postgraduates of Medicine 2015;38(1):25-28
Objective To investigate the effect of intranasal instillation of insulin with different doses on cognitive function in patients with Alzheimer disease (AD).Methods Sixty-three AD patients were collectcd.According to the order of doctor's office visiting,they were divided into insulin 1 group (21 cases,intranasal instillation of insulin 20 U,2 times per day),insulin 2 group (21 cases,intranasal instillation of insulin 40 U,2 times per day) and placebo group (21 cases,intranasal instillation of physiological saline,2 times per day).Mini-mental state examination scale (MMSE) and Rivermead behavioural memory test second edition (RBMT Ⅱ) were used to evaluate the improvement of cognitive function after 3 months and 6 months.Results Before treatment,the scores of MMSE and RBMT Ⅱ in insulin 1 group were (20.2 ± 2.3) and (17.2 ± 1.9) scores,in insulin 2 group were (20.7 ± 2.8) and (16.5 ± 1.9) scores.After treatment for 3 months,the scores of MMSE and RBMT Ⅱ in insulin 1 group were (21.8 ± 3.2) and (19.2 ± 2.0) scores,in insulin 2 group were (21.6 ± 3.5) and (18.1 ± 2.0) scores.The scores of MMSE and RBMT Ⅱ in insulin 1 group and insulin 2 group significantly improved compared with those before treatment (P < 0.05 or < 0.01).But the scores of MMSE and RBMT Ⅱ in placebo group were significantly aggravated,(18.9 ± 3.8) scores vs.(20.9 ± 2.5) scores,(15.2 ± 2.1) scores vs.(16.1 ± 2.0) scores,P < 0.05.After treatment for 6 months,the scores of MMSE and RBMT Ⅱ in insulin 1 group were (22.5 ± 3.3) and (20.5 ± 2.0) scores,in insulin 2 group were (22.7 ± 3.1) and(19.8 ± 1.9) scores,and in placebo group were (17.9 ± 4.5) and(14.7 ± 2.0) scores.The scores of MMSE and RBMT Ⅱ in insulin 1 group and insulin 2 group were significantly better than those in placebo group (P < 0.01).Conclusion Intranasal instillation of insulin can improve cognitive disorders in patients with AD.
4.Expressions of transcription factor activator protein-2α, estrogen receptor-β and matrixmetalloproteinase-9 in lichen planus lesions
Chinese Journal of Dermatology 2011;44(5):339-342
Objective To determine the expressions of transcription factor activator protein-2α (AP-2α), estrogen receptor-β (ER-β) and matrixmetalloproteinase-9 (MMP-9) in lichen planus (LP) lesions and their significance. Methods Tissue samples were resected from the lesions of 30 patients with LP and normal skin of 30 human controls. An immunohistochemical method using streptavidin-peroxidase (SP) was performed to detect the expression of ER-β and MMP-9, reverse transcription-PCR and Western blot to measure the mRNA and protein expressions of AP-2α, ER-β and MMP-9 in these specimens. Results There was a significant decrease in the mRNA expressions of AP-2α (0.488 ± 0.039 vs. 1.008 ± 0.023, P < 0.01 ) and ER-β (0.365 ± 0.032 vs. 0.998 ± 0.036, P < 0.01), together with an increase in the expression of MMP-9 (1.237 ± 0.027 vs. 0.567 ± 0.015, P< 0.01) in the LP lesions compared with the control specimens; similar results were observed for the protein expressions of AP-2α, ER-β and MMP-9. In LP lesions, the expression of AP-2α was positively correlated with that of ER-β (R = 0.89, P < 0.01), but negatively correlated with that of MMP-9 (r = -0.91, P < 0.01). Conclusions The down-regulation of ER-β expression and up-regulation of MMP-9 expression may be ascribed to the abnormal regulation of upstream target genes mediated by the decreased expression of AP-2α, which may be involved in the pathogenesis of LP.
6.Therapeutic effect of rosuvastatin on patients with hyperlipidemia complicated hyperuricemia
Chinese Journal of cardiovascular Rehabilitation Medicine 2016;25(6):604-606
Objective:To evaluate therapeutic effect and safety of rosuvastatin on patients with hyperlipidemia com‐plicated hyperuricemia .Methods :A total of 88 patients with hyperlipidemia complicated hyperuricemia ,who were hospitalized in our hospital ,were selected ,randomly and equally divided into rosuvastatin group (10 mg/d) and atorvastatin group (20 mg/d) ,both groups were treated for eight weeks .Changes of levels of blood lipids and serum uric acid (SUA) were observed and compared between two groups before and after treatment .Results:Compared with before treatment ,after eight -week treatment ,there were significant reductions in levels of blood lipids (ex‐cept high density lipoprotein cholesterol ) and SUA in both groups , P<0.01 all;compared with atorvastatin group after treatment ,there were significant reductions in levels of total cholesterol [ (4.87 ± 0.47) mmol/L vs .(4.48 ± 0.53) mmol/L] in rosuvastatin group (P=0.04) ,and there was no significant difference in SUA level between two groups , P>0.05. There were all no more serious side effects in both groups .Conclusion:While reducing blood lipid levels ,rosuvastatin can also reduce serum uric acid level in patients with hyperlipidemia ,and it possesses good safety and tolerance .
7.CHANGES OF ? ADRENERGIC RECEPTORS AND ANGIOTENSIN Ⅱ RECEPTORS IN SPONTANEOUSLY HYPERTENSIVE RATS AND DIFFERENT AGES WKY RAT HEARTS
Medical Journal of Chinese People's Liberation Army 1981;0(06):-
To study the changes of ? adrenergic receptor subtypes (? 1 AR,? 2 AR) and angiotensin Ⅱreceptor subtypes (AT 1 R,AT 2 R)mRNA levels in spontaneously hypertensive rat (SHR) hearts at 14 weeks of age, and WKY rat hearts at ages 14 and 48 weeks, the total cellular RNA was extracted from the left ventricular tissue, and reverse polymerase chain reaction analysis was performed for measurement of the four receptors. The expression levels of ? 1 AR mRNA and ? 2 AR mRNA were down regulated in WKY hearts at age 48 weeks and in 14 week SHR. AT 1 R mRNA levels were decreased in 48 week WKY and 14 SHR, and AT 2 R mRNA levels were significantly increased in SHR. The expression levels of ? 1 AR and AT 1 R mRNA were declined following the increase of ages. The levels of ? 2 AR mRNA were down regulated in hypertension and myocardial hypertrophy conditions first because ? 2 AR was more sensitive to myocardial hypertrophy than ? 1 AR. Long term and hyper AngⅡ levels stimulated AT 1 R mRNA down regulation in SHR, and it is the myocardial hypertrophic compensatory process that increases the AT 2 R mRNA levels.
8.Using Shenghua decoction though syndrome differentiation following childbirth
China Journal of Traditional Chinese Medicine and Pharmacy 2006;0(09):-
Shenghua decoction made by FU Qing-zhu is a famous formula aimed at syndrome of coagulation cold due to blood deficiency,static blood obstruction.The mechanism of disease is definite when this formula is applied.But the extensive use of Shenghua decoction,especially some potent preparation of it following childbirth without according to TCM principle based on differentiation of syndromes is a manifestation of highlighting formula and underestimating theory,which is useless and harmful.It should be emphasized.So the Shenghua decoction should be used under the direction of basic theory of TCM,through precise syndrome differentiation,according to the principle of "looking to and not being besieged by postpartum ".We should not follow blindly the method of treatment of "warming and resolving stasis" on the postpartum disease.It is important that Shenghua decoction should be used on the basis of syndrome differentiation.
9.Tongue Research Overview
Journal of Zhejiang Chinese Medical University 2013;(11):1363-1366,1367
[Objective] To understand Chinese scholars in different periods on the different understanding of tongue, for further development of research and provide a theoretical basis. [Method] Access to a large number of ancient books and literature, selection and tongue of related articles, extract and summa-rize the main points. [Result] The ancient understanding of TCM tongue is very knowledgeable, and by the subjective leading generation, does not have the scientific rigour;modern research of Chinese medicine tongue is mainly from the tongue and tongue color, tongue shape and other aspects, the objec-tive diagnosis and analysis system, the research methods of modern TCM tongue with scientific rigor modern Chinese Medicine; from the point of view, different degrees of col aterals and the width of the color purple tongue, sublingual y reflect the progress of the blood stasis degree and disease conditions, different diseases have different characteristics of the tongue. [Conclusion] Research on the development of modern tongue made certain contribution to TCM development.
10.Advance of Application of Micro Positron Emission Computed Tomography in Cerebral Ischemia Model (review)
Chinese Journal of Rehabilitation Theory and Practice 2017;23(7):770-774
Micro positron emission computed tomography (PET) is a sort of tomography technique specifically for small animal stud-ies. It can be used to observe radionuclide labeling molecules in vivo, especially for neuronal activities noninvasively, dynamically and quan-titatively at the molecular level. MicroPET can be used for early detection of atherosclerotic plaques, measurement of cerebral blood flow, judgment of the survival status in cerebral ischemia area in animal model. It is important for the control of risk factors, disease diagnosis, dis-ease staging and evaluation of curative effect.